Member Info for djwall1s

He's got given, yet again, the most amazing opportunity, out of the sky (because he always seems to fall on his feet), to make a winner out of this product.

We are genuinely, suddenly, after many years of sci-fi tales and people with warnings being branded as cranks, living on the cusp of dystopia. Where the shamdemic has ushered in compliance, fear, and accordingly digital fiat now looming right around the corner, thanks to the WEF and WHO, and our utterly wet, weak leaders.

So not just investors, but regular ordinary people who didn't dabble, are on the hunt for safe havens away from banks and fiat. What was a cute, niche product many sneered at, including on here, could be a suddenly really valuable tool against the madness we see unfolding around us as world governments streamline everything into box ticking digital systems, no doubt linked to your ID eventually. Will gold and Tally be exempt from that? Who knows in time, but at the present moment, yes.

I do think Tally will list. I always have. But it'll be in CP's time and it's time that is now running out.

The trouble is we just lollop from month to month, Q and A to another Q and A and we have no clue what he's actually doing in between.

I'd like to know some solid 'We have a listing brochure ready to go, it's written, a date for listing and a timetable' but nope. We just await the next Q and A to be told its over the next hill.

I'm glad we're still here but it's staggering to me that we are.

Today 07:00

RNS Number : 2739J

Ananda Developments PLC

15 August 2023

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

NHS SCOTLAND TO FUND MRX1 ENDOMETRIOSIS TRIAL

Ananda Developments plc (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory pain conditions, is pleased to announce that the Chief Scientist Office ("CSO"), which is part of the Scottish Government Health Directorate and is responsible for funding research in NHS Scotland (NHS) is providing the non-dilutive funding for the previously announced endometriosis randomised controlled trial ("RCT") using Ananda's MRX1 sublingual cannabidiol oil. The CSO is providing £300,000 to conduct the trial using Ananda's patent pending MRX1 formulation and matching placebo.

The endometriosis RCT will be conducted by Dr Lucy H R Whitaker (BSc (Hons) MB ChB MSc MD MRCOG), NES CSO Clinical lecturer in Obstetrics and Gynaecology at The University of Edinburgh. Dr Whitaker is supported by Professor Andrew W Horne (PhD, FRCOG, FRCP Edin, FRCSEd, FRSE), Professor of Gynaecology and Reproductive Sciences at The University of Edinburgh. Prof Horne is also Co-director of EXPPECT Edinburgh, Specialty Advisor to Scotland's Chief Medical Officer for Obstetrics and Gynaecology, President-elect of the World Endometriosis Society & Co-Editor in chief of Reproduction and Fertility. The 100 endometriosis RCT participants will take Ananda's patent pending MRX1 cannabidiol oil or matching placebo.

Melissa Sturgess, CEO of Ananda, commented "Our objective is to have MRX1 included by the NHS as an efficacious and cost-effective treatment for pain associated with endometriosis. Getting NHS funding for this trial using MRX1 is a clear statement of the importance of endometriosis as a public health issue and we believe clearly demonstrates the interest in the use cannabidiol as a potential treatment for endometriosis and other complex chronic inflammatory pain conditions by the UK's public health bodies. The chronic, complex inflammatory pain market was recently estimated (https://www.england.nhs.uk/blog/anthony-woolf/) to be worth at least £5 billion per annum in the UK alone."

For further information about the use of MRX1 in clinical trials please contact nick.clarkson@mrxmedical.com and for all other MRX enquiries, including for MRX1 to be prescribed by specialists, please contact Jack@anandadevelopments.com

Further information on the trial:

TCS/22/28 - ENDOCAN-1: A Pilot Randomised Controlled Trial Of The Efficacy Of A Cannabinoid Oral Tincture In The Management Of Endometriosis-Associated Pain.

--------------------------------------------

More at RNS tab above...

Where do you suggest we all 'move on' to? When it's our money, including some quite substantial holdings, that we'd rather like to see again.

I suggest you move on, Justice. If you're trolling, don't bother and if you're a holder who has given up then you do you. If there's a chance to get this back to market as a genuine holder you should be gunning for it.

Today 17:44

RNS Number : 8031H

Ananda Developments PLC

31 July 2023

31 July 2023

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

Completion of Audit, Publication of Annual Report and Accounts and Notice of Annual General Meeting

Further to the announcement of its 2022/23 unaudited preliminary results on 13 July 2023, Ananda announces that the audit for the year ended 31 January 2023 has now been completed. Adjustments have been made to the previously notified Consolidated Statement of Cashflows and Balance Sheet, which are reflective of adjustments made a part of a review of the acquisition of DJT Group Limited, revised tables are set out below.

The Company's Annual Report and Accounts for the year ended 31 January 2023, together with a Notice of Annual General Meeting, has been published on the Company's website. The notice of Annual General Meeting have also today been posted to, or emailed to, shareholders as appropriate in accordance with the provision in the Company's articles of association on electronic communications.

The Annual General Meeting is due to be held at the offices of Shakespeare Martineau Llp, 6th Floor, 60 Gracechurch Street, London, EC3V 0HR at 2.00pm on 24th August 2023.

Statement of Financial Position...

(Rest see under RNS tab above).

July 1st:

https://www.theargus.co.uk/news/23605366.mastercard-brighton-art-student-thrilled-design-chosen/

Centralised banking is heading our way apace, and it's absolutely terrifying to me tbh. I don't think most people even understand what the end game is but it's not pretty from what I've read, whether it happens or not. Any, ANY form of an alternative, for however long we can fight this totalitarian-style nonsense should be not only welcomed but ushered in as fast as possible. He could have a mega boom on his hands if he allowed it to fulfil its full potential, but as long as he's just confining it to a corner of Twitter it'll never happen. GB News was a really good start though, and I commend him for either listening to people, or coming to that conclusion himself.

Treble will know this but CP ended on quite a salty note last night, firing something back at a poster about being 'an adult.'

He views people as naughty children out to trip him up, rather than thoroughly fed up, demoralised shareholders whose money his company has literally held to ransom, locked away from them for going on 6 years, no help from the FCA, no help from anyone. We've just had to wait while he changes his mind relentlessly, builds peoples hopes and dashes them. That's not to say he hasn't achieved good things too, but I object to the obvious porkers about listing years ago whilst obviously knowing they were nowhere near that. Some stuff were out of Tally's control, namely the AIM boot, pandemic, and wider economic forces. But CP is the architect of where he finds himself now imo. I hope he can turn it around with a new chapter. I'm cautiously and mildly optimistic but only mildly. With heavy disappointment mode activated for the umpteenth time. Let's see how it goes.

Valid, but personally I could wait a bit longer for 4p if a listing for that was bob on, confirmed in the coming weeks. And if so I might even hang onto some of my holding.

A solid date is unlikely to happen given his track record of broken promises and we could well be in for a total pants downer next Q and A. It has become so commonplace for him to change his mind and goalpost shift it's not really worth getting excited about or looking forward to without disappointment.

However, a fool's hope remains imo, and that did win a great war in LoTR.

True SL, but at least with the uptick in available and now disclosed funds we are nearer listing than we ever were. The last lap is down to him.

As I say I'd take 2024 all day long if it were concrete and confirmed, documents ready to go, stuff signed. But it's always vague 'let's aim for it and see where we are based on x, y, z' noises. Highly nebulous, and people, understandably, have had their fill of it. But the more raised profile in the media Tally gets the more CP can be held to account re: his perennially very wobbly word. At some point he's going to have to just get on with it, get it listed on a stock exchange and that alone will create a large part of what's needed for this company. The rest is down to product and good management/a good team.

The only mitigating factor I can give them is that they are a small team. To scale up to meet potential demand they'd have to take on more staff. That may or may not happen but it's a factor imo. Especially if they do get a realistic boost from people fleeing mainstream banks for alternative safeholdings. The Tally app is at times riddled with issues to this day, so they're going to have to shape up if they want anything like a 'seat at world banking.' They could actually get their legs under a nearby table if they play their cards right. A ton depends upon him pulling his finger out and being decisive, not just with making sure the product runs smoothly and counters everyday issues, but with listing this company.

Well when you've put down the salt that you're aiming at me for some odd reason, I'm sure you're capable of dropping them a line. It's an Ananda company so you can obviously contact HQ and there are numerous ways of contacting MRX, which is basically Ananda, on that page.

Usually people find out what's what for themselves, not sit back, throw shade and then wait for others to ask the questions they themselves are chasing.

"With 760m shares in issue, at 3p = £22.8m".

He also amended the 22m to 23m in the previous statement.

"pre-IPO sees the group valued at £23m pre-money."

He also talked a bit about Nigel and the increase in traffic to the Tally website on the back of the GB News push. Someone suggested a slot with Liam Halligan, and though I can't atm see if he responded to that, I'd definitely say that'd be an excellent idea. It doesn't take much to become a GB News regular. Just hang around the canteen for long enough and get yourself on Mark Dolan's panel. He could be well in.

Oh lord, he got pelted tonight from practically everyone, lol, even Jazzy turned up again and Pineapple, who I love. :D It was a big old poo-flinging contest if ever there was, and he's had it coming tbf.

Virtually all the questions were about relist and there was no good old JonnyE and couple of others (who usually ask more tevhnical/ops-based questions) to save him.

Below are his replies about relist, which of course, well, you know the drill. Usual caveats, etc...

Perhaps the second most valuable question after when, is at the very bottom. Decide for yourselves. CP is just finishing answering questions as I type. I checked in after it closed but he was still mopping up. It was probably one of the more hostile sessions I've seen tbh, but he did, as he always does, turn up for it and answer questions, whether it's what people want to hear or not. So props to him at least for that. The main relist answers are below.

"Regarding potential timing for listing, I believe we’re still a chance of getting Tally’s shares listed by Christmas this year, but with all our other ongoing work streams, we’ll know a lot more as we go into October."

"... we’re open to raising additional pre-IPO funds this quarter. It doesn’t relate directly to revenues (but of course we need to keep growing revenues)."

"I have my views and target range on IPO price xxx but it’ll be affected by numerous things between now and the end of the year. I will say that the pre-IPO price is 3p so obviously we’d be looking at a price higher than that."

"Evening xxxxx, recent tangible steps towards listing have included among other things: ongoing product development, expanding the capability of the organisation, growing awareness and traction in the UK market, going live with our proprietary technology platform, and converting non-core investment assets to useful current assets. I suppose me appearing in the press helps show we’re pushing forward with the concept, the business and the strategy (that includes a public company listing). Agreed it’s taken an extremely long time (it’s also been extremely hard work)."

"pre-IPO sees the group valued at £22m pre-money."

I missed it as had a late tea, but here's Cameron's opening statement:

"Dear fellow Shareholders, July has been a pivotal month for Tally Central Ltd.

July saw us continue to test and improve our systems, processes and service providers.

The big breakthrough was that we completed the sale of our Finland gold exploration interests to BSE-listed, Deccan Gold Mines Ltd. In addition, Deccan Gold Mines share price has made a step change from when our first deal was done end of last year and our Finnish deal was agreed.

We were also able to gain some good PR exposure this month, around the Coutts/Natwest banking scandal. If of interest, you can view these GB News appearances here:

link provided in page"

2.6k views on that linked news segment alone to date, where you'd normally get around 90 views on a Tally YT advert in the same time frame, and if you were lucky a few hundred.

Of course the vast majority won't chase down a Tally account but the more he can push the Tally product out towards ordinary folk who may just follow it up whilst browsing the net, the better. I commend him for this. He's usually in the doghouse round here but I give CP credit for putting feelers out on GB News. Next step is to let them do a proper, focused segment on this alternative product. Right now we need all the alternatives we can get. Tally could be onto a good opening here thanks to this Nat West fiasco.

Liam's ace, he really knows his onions. As I say, Tally going to GB News is going to get thd word out far more than flapping about on Twitter and quiet corners of YouTube. But how Tally handles its customers is what ultimately will make or break it.

Sorry, dunno why the word 'pack' went into caps lock territory, my phone sometimes does this. Nothing intentional meant with that.

Are you a registered medical professional, Gaz? Because that's the only way, by law, you're going to get further info from them about their products via MRX.

If you are, you can apply online at MRX and they'll send you a PACK. The website is not intended to be for the general public and I was aware of that on visiting. It's clearly for industry professionals only.

The issue appears to be an individual one related to the customer, now being dealt with by Kris. But always worth keeping an eye on the forum if you can, not everyone who posts there posts here or vice versa.

Another poster has tried to reassure by saying their issue was rectified by sending in additional documentation but that the way Tally have handled this (if true) is poor.

The OP has had that message on the forum for literal hours and nobody from Tally has even responded. It's taken a shareholder to respond to them to try to help.